Back to News
Jan 14, 2026 12:00 PM

Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges

Plus Therapeutics Inc. (NASDAQ:PSTV) stock is down during trading session on Wednesday following the company’s announcement of a public offering.

The stock’s decline comes as the broader markets experienced a mixed session, with major indices like the S&P 500 and Nasdaq both closing lower on the previous trading day.

The company priced its underwritten public offering at $0.38 per unit, consisting of one share of common stock and one warrant, aiming to raise approximately $15 million before expenses.

PSTV stock closed at $0.47 on Tuesday.

This offering is expected to close on January 15, 2026, and the proceeds will be used for working capital and general corporate purposes.

Plus Therapeutics ...